TCO (10)

Dr. Hasan Siddiqui

Scientific Review Officer

• hasan.siddiqui@nih.gov Send A Message
• 301-451-0395

This small business panel reviews grant applications related to diagnosis and treatment of cancer. This includes identification of biomarkers as prognosticators of cancer, assay development for cancer diagnosis and prognosis, and use of novel technologies to monitor cancer therapy. Additionally, applications addressing nutrition, dietary, natural products and other chemopreventive factors are considered in this SEP.Review DatesA roster for the panel will be posted here, at least 30 days prior to the review meeting

Topics

• Discovery and validation of biomarkers for cancer detection, diagnosis, prognosis, and therapeutic responses
• Development of novel assays, use of instrumentation and algorithms for cancer screening, diagnosis, prediction of metastasis, recurrence, and drug responses
• Basic, pre-clinical and clinical testing for tumor genetic and epigenetic markers
• Pre-clinical and clinical modeling of carcinogenesis, tumor development, metastasis, and cancer treatments
• Development and evaluation of cancer prevention strategies (including diets/nutritional herbs and natural products) in preclinical models and translational studies leading to pilot and/or phase-1 clinical trials
• Testing of computational models for cancer risk prediction

Discover Other Possible Study Sections

Return to Top